Data for 2017 indicate that there were more than 47,000 opioid-involved overdose deaths, and one in eight adults now reports having had a family member or close friend die from opioids. Increasing the availability and reducing the costs of approved medications for those with an opioid use disorder (OUD) is imperative; however, jurisdictions addressing OUDs and overdose may wish to consider additional interventions. Download (RAND)
Bibliography: Interventions – Harm Reduction
Rights, Respect and Recovery (PDF)
Scotland’s strategy to improve health by preventing and reducing alcohol and drug use, harm and related deaths (Scottish Government)
National Naloxone Programme Scotland Monitoring Report 2017/18 (PDF)
A total of 8,397 take-home naloxone kits were issued in Scotland in 2017/18, an increase of 3% from the previous year (NHS National Services Scotland)
Hepatitis C treatment monitoring in England
Preliminary findings from the Hepatitis C patient registry and treatment outcome system (Public Health England)
Canadian Substance Use Costs and Harms in the Provinces and Territories (2007–2014) PDF
The aim of this document is to provide these detailed costs so that researchers, decision makers and others can use them to inform policies and programs at the provincial and territorial levels (CCSA)
Criminal exploitation and ‘county lines’: learn from past mistakes, report finds
Report finds that local agencies must learn lessons from past sexual exploitation cases to respond to ‘county lines’ and other child criminal exploitation (Ofsted, Care Quality Commission, HM Inspectorate of Probation, and HM Inspectorate of Constabulary and Fire & Rescue Services)
Opioid harm in Australia: and comparisons between Australia and Canada
This report shows that opioid harms are an issue in both Australia and Canada. Rates of opioid deaths and opioid poisoning hospitalisations in Australia increased in the last 10 years. In 2016, pharmaceutical opioids were involved in more opioid deaths and opioid poisoning hospitalisations than heroin (AIHW)
20 years of the Methadone Treatment Protocol in Ireland
This is an overview of the ICGP Substance Misuse Programme as it has developed with particular reference to the 20 years of the Methadone Treatment Protocol which came into effect October 1998 (Irish College of General Practitioners)
Preventing overdose deaths in Europe (Perspectives on drugs)
More than 9 000 lives were reported to be lost to drug overdoses in Europe (28 EU Member States, Turkey and Norway) in 2016, the latest reporting year, and this is an underestimate Download (EMCDDA)
Alcohol, drugs and tobacco: commissioning support pack
Annual guidance on smoking, drinking and drug misuse for commissioners of tobacco control, drug and alcohol services for adults and young people (Public Health England)
Preventing overdose deaths in Europe (Perspectives on drugs)
More than 9 000 lives were reported to be lost to drug overdoses in Europe (28 EU Member States, Turkey and Norway) in 2016, the latest reporting year, and this is an underestimate. Download (EMCDDA)
European evidence-based guidance on prevention and control of HCV in prison settings (poster)
Prisons are settings of increased risk for HCV transmission, while representing a unique opportunity to address the healthcare needs of those people in prison who belong to hard-to-reach and medically underserved groups in the community, such as people who inject drugs – download (EMCDDA)
5-Point Strategy To Combat the Opioid Crisis
HHS has a comprehensive strategy to empower local communities on the frontlines. The opioid epidemic is one of the Department’s top priorities. In 2017, HHS launched a 5-point Opioid Strategy
Criminal exploitation of children and vulnerable adults: county lines
Guidance for frontline professionals on dealing with county lines, part of the government’s approach to ending gang violence and exploitation (Home Office)
Best Practices across the Continuum of Care for the Treatment of Opioid Use Disorder (PDF)
disorder in Canada should have access to comprehensive treatment options that meet all their needs. Best Practices across the Continuum of Care for the Treatment of Opioid Use Disorder presents services that should be available to individuals experiencing or at risk of experiencing harms from opioid use (CCSA)
Heroin On Trial
Presentations from the conference (SSA)
Hepatitis C in England and the UK
Latest PHE hepatitis C virus (HCV) reports, slide sets and infographics for England and the UK (Public Health England)
Naloxone-on-Release (PDF)
Guidelines for naloxone provision upon release from prison and other custodial settings (project is co-funded by the European Union under the Justice Programme)
The public health burden of alcohol: evidence review
This review looks at the impact of alcohol on the public health and the effectiveness of alcohol control policies (Public Health England)
National MATOD summit report
Key Outcomes of the National Summit (Harm Reduction Australia)
People who inject drugs: HIV and viral hepatitis monitoring
Data tables and commentary for the unlinked anonymous monitoring surveys of infections and risk among people who inject drugs (Public Health England)
Public health guidance on prevention and control of blood-borne viruses in prison settings
This evidence-based guidance aims to support the planning and implementation of effective programmes to prevent and control the transmission of infectious diseases in prison settings in the European region (EMCDDA)
The lost decade
Neglect for harm reduction funding and the health crisis among people who use drugs (Harm Reduction International)
Guidelines for naloxone provision upon release from prison and other custodial settings
This work is a product of the project “My first 48 hours out – comprehensive approaches to pre and post prison release interventions for drug users in the criminal justice system”. The project, led by the Frankfurt University of Applied Sciences/Germany, received funding from the European Union for the period 2017-2018
Drug health harms: national intelligence
Briefings based on presentations and discussion from the meeting of the national intelligence network on the health harms associated with drug use (Public Health England)
Dying on the Streets: The case for moving quickly to end rough sleeping
This report explains why it can be hard to escape the streets and what should be done to prevent further deaths of people sleeping rough. It is based on a national survey of outreach teams who work with people living on the streets night and day (St Mungo’s)
Most students think taking illegal drugs causes problems for users as well as society and want their universities to take a tougher stance
The Higher Education Policy Institute and the University of Buckingham have worked with YouthSight on a survey of attitudes towards drugs among full-time undergraduate students
Public health guidance on active case finding of communicable diseases in prison settings
What are the most (cost-) effective ways to prevent and control communicable diseases in prison settings? (EMCDDA)
Addressing the impact of nondependent parental substance misuse upon children (PDF)
A rapid review of the evidence of prevalence, impact and effective interventions (Public Health England)
Fentanyl: preparing for a future threat
Incident planning for potent opioids arriving into the illicit drug market (Public Health England)
Hepatitis C in England and the UK
Latest hepatitis C virus (HCV) reports, slide sets and infographics for England and the UK (Public Health England)
Alcohol and other drug treatment services in Australia 2016–17: key findings
In 2016–17, 836 publicly-funded alcohol and other drug treatment services provided just over 200,000 treatment episodes to an estimated 127,000 clients (AIHW)
Substance Use and Aging (PDF)
This document was published by the Canadian Centre on Substance Use and Addiction (CCSA)
Needle and Syringe Programs in Australia: Peer-led Best Practice
Global review of drug checking services operating in 2017
This bulletin sought to identify and document the features of drug checking services operating worldwide as at 2017. In this bulletin we profile 31 drug checking services operated by 29 organisations, spanning 20 countries across Europe, the Americas and Australasia (NDARC / DPMP)
Hepatitis C in England 2018 report (PDF)
In this report, we summarise the impact of action plans in England to drive down mortality from HCV, reduce the number of new infections, and outline the actions required to make further progress (Public Health England)
Night Lives: Reducing Drug-Related Harm in the Night Time Economy
The UK’s night time economy is failing to protect its most valuable asset: the people who go out and enjoy it. Night Lives: Reducing Drug-Related Harm in the Night Time Economy, a joint report by the All-Party Parliamentary Group for Drug Policy Reform, Durham University
The misuse of synthetic opioids (PDF)
harms and clinical management of fentanyl, fentanyl analogues and other novel synthetic opioids Information for clinicians (NEPTUNE group)
Our Invisible Addicts (2nd edition)
This report, which has been developed with representation from a patient, the Royal College of Psychiatrists, the Royal College of General Practitioners and the British Geriatrics Society, provides the latest milestone on the journey towards developing the best possible response to this important problem
Implementing Supervised Injection Services (PDF)
This nursing best practice guideline (BPG) is a comprehensive document that provides an overview of principles, resources, and structures for delivering evidence-based supervised injection services (Registered Nurses’ Association of Ontario)
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- …
- 12
- Next Page »
